1.1.1.71	(R)-2-hydroxypropiophenone	-	166290	
1.1.1.71	2-mercaptoethanol	slight inhibition	63	
1.1.1.71	4-chloromercuribenzoate	0.01 mM, complete inhibition	388	
1.1.1.71	4-chloromercuribenzoate	0.01 mM, complete inhibition; some protection of partial inhibition resulting from 0.001 mM 4-chloromercuribenzoate in the presence of 1 mM NADP+, almost complete protection with 10 mM hexan-1-ol	388	
1.1.1.71	4-chloromercuribenzoate	1 mM, 100% inhibition	388	
1.1.1.71	4-chloromercuribenzoate	-	388	
1.1.1.71	8-hydroxyquinoline	1 mM, 100% inhibition with NAD+ as cofactor, 40% with NADP+ as cofactor	321	
1.1.1.71	acetonitrile	complete inhibition in buffer without NaCl and in buffer with 600 mM NaCl	981	
1.1.1.71	Ag+	-	75	
1.1.1.71	AgNO3	1 mM, 100% inhibition	360	
1.1.1.71	Ca2+	-	15	
1.1.1.71	CdCl2	1 mM, 24% inhibition with NAD+ as cofactor	906	
1.1.1.71	chloroform	21% inhibition in buffer without NaCl, 19% inhibition in buffer with 600 mM NaCl	4509	
1.1.1.71	Co2+	-	23	
1.1.1.71	Cu2+	-	19	
1.1.1.71	CuSO4	1 mM, 75% inhibition with NAD+ as cofactor, 56% with NADP+ as cofactor	263	
1.1.1.71	Cyclohexanol	-	873	
1.1.1.71	Dimethyl formamide	87% inhibition in buffer without NaCl, 59% inhibition in buffer with 600 mM NaCl	12511	
1.1.1.71	dimethyl sulfoxide	complete inhibition in buffer without NaCl, 60% inhibition in buffer with 600 mM NaCl	1217	
1.1.1.71	EDTA	10 mM, 20% inhibition	21	
1.1.1.71	EDTA	5 mM, 20% inhibition; 5 mM, 80% of initial activity	21	
1.1.1.71	EDTA	complete inhibition at 1 mM	21	
1.1.1.71	ethyl acetate	complete inhibition in buffer without NaCl, 67% inhibition in buffer with 600 mM NaCl	2738	
1.1.1.71	Fe2+	10 mM, 74% of initial activity	25	
1.1.1.71	Fe2+	no activity at 1 mM	25	
1.1.1.71	FeSO4	1 mM, 75% inhibition with NAD+ as cofactor, 46% with NADP+ as cofactor	655	
1.1.1.71	FeSO4	10 mM, 26% inhibition	655	
1.1.1.71	HgCl2	1 mM, 100% inhibition	110	
1.1.1.71	iodoacetamide	1 mM, complete inhibition	67	
1.1.1.71	iodoacetic acid	1 mM, 29% inhibition with NAD+ as cofactor, 80% with NADP+ as cofactor	213	
1.1.1.71	methanol	75% inhibition in buffer without NaCl, 81% inhibition in buffer with 600 mM NaCl	83	
1.1.1.71	Mg2+	10 mM, 78% of initial activity	6	
1.1.1.71	Mg2+	slight inhibition	6	
1.1.1.71	additional information	dithiothreitol and EDTA have no effect on either oxidative or reductive activity	2	
1.1.1.71	additional information	the Fe2+-reconstituted Ni-PhADH was sensitively and rapidly inactivated by dioxygen gas. The enzyme is inactivated by the replacement of the ferrous ion in the active site with another metal ion such as a zinc ion, which has been considered an inhibitor of iron-activating group III ADHs	2	
1.1.1.71	n-decane	9% inhibition in buffer without NaCl, slight activation in buffer with 600 mM NaCl	138675	
1.1.1.71	N-ethylmaleimide	1 mM, complete inhibition	49	
1.1.1.71	N-ethylmaleimide	strong inhibition	49	
1.1.1.71	n-hexane	40% inhibition in buffer without NaCl, slight activation in buffer with 600 mM NaCl	14171	
1.1.1.71	Ni2+	14% residual activity at 1 mM	38	
1.1.1.71	o-phenanthroline	1 mM, 100% inhibition with NAD+ as cofactor, 40% with NADP+ as cofactor	239	
1.1.1.71	o-phenanthroline	1 mM, 30% inhibition after 3 h incubation	239	
1.1.1.71	p-hydroxymercuribenzoate	strong inhibition	98	
1.1.1.71	Phenobarbital	0.5 mM, 30% inhibition	1475	
1.1.1.71	pyrazole	0.5 mM, 35% inhibition	1078	
1.1.1.71	Sodium azide	10 mM, 40% inhibition	447	
1.1.1.71	Sodium glycocholate	-	30408	
1.1.1.71	Tween 80	-	514	
1.1.1.71	Zn2+	10 mM, 79% of initial activity	14	
1.1.1.71	Zn2+	14% residual activity at 1 mM	14	
1.1.1.71	ZnSO4	10 mM, 21% inhibition	485